US Stocks Result Analysis for Industry - Specialty Pharmaceuticals for the month ending Mar 31, 2025
Analysis of which stocks have performed the best and worst in Industry - Specialty Pharmaceuticals for the month ending Mar 31, 2025 on the basis of sales/revenues, profits and profit margins. Only companies which have declared results in the current month are considered.
Choose Stock universe, Portfolio or index
Note: Industry-level growth metrics have been calculated by totaling the numbers of all companies in that industry, to get an average.
0
POSITIVE PROFIT GROWTH
1
NEGATIVE PROFIT GROWTH
0
NEUTRAL PROFIT GROWTH
0
%
TOTAL REVENUE GROWTH
0
%
TOTAL EBIDT GROWTH
48.6
%
TOTAL OPER. PROFIT GROWTH
Positive
Negative
Pending
Profit Growth
Awaiting more industry results. Scroll down for table.
MAR-24
-0.6 US$ Mn
MAR-25
-3.0 US$ Mn
Lowest Profit Growth
Operating Profit Growth
MAR-24
-1.9 US$ Mn
MAR-25
-1.0 US$ Mn
Highest Operating Profit Growth
Awaiting more industry results. Scroll down for table.
| Stock | Market Capitalization | Operating Revenue Qtr | Revenue Growth Qtr YoY % | Revenue Surprise Qtr % | Net Profit Qtr | Net Profit Qtr Growth YoY % | Net Profit Surprise Qtr % | Operating Profit Qtr | Operating Profit Growth Qtr YoY % | EBIDT Qtr | EBIDT Qtr growth YoY % | Operating Profit Margin Qtr % | Operating Profit Qtr Margin% YoY Change | Last Result Updated |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PharmaCyte Biotech Inc |
8.44
|
0.00
|
-
|
-
|
-3.05
|
-391.55
|
-
|
-0.96
|
48.62
|
0.00
|
-
|
-
|
-
|
17-Mar-2025 |
Powered by
